We use cookies to give you the best possible experience on our website.

NICE Implementation Collaborative (NIC)
 

The NIC is a unique partnership between the NHS, Life Sciences industry, Healthcare professional bodies, key health organisations and Patient groups. NIC partners are committed to working together to support a system where patients have faster and more consistent access to NICE-recommended medicines, treatments and technologies and is a collaboration which completely re-draws the landscape. Industry will now work with academia, clinical groups, NHS England, NICE and representative bodies to drive compliance with NICE recommendations.

The partnership underpinned by the signing of a concordat in March 2013. The Concordat is made up of the following members:

  • Academy of Medical Royal Colleges
  • Association of British Healthcare Industries (ABHI)
  • Foundation Trust Network
  • NHS Alliance NHS
  • Commissioning Assembly
  • NHS Confederation
  • NHS England
  • National Institute for Health and Care Excellence (NICE)
  • Patients Involved in NICE
  • Royal Pharmaceutical Society
  • The Academy of Medical Sciences
  • The Association of the British Pharmaceutical Industry (ABPI)
  • The British In Vitro Diagnostics Association (BIVDA)

What does the NIC do?

  1. Identify practical measures that support and promote timely and consistent implementation of NICE Technology Appraisals throughout the NHS in England
  2. Work jointly to support and promote the adoption of all other forms of NICE guidance that apply to the NHS in England, and to drive the uptake of innovation, in a way that is consistent with local health needs and priorities
  3. Understand the barriers that restrict expected levels of implementation and uptake, including the requirement for CCGs to provide care for their populations taking into account local affordability and clinical need. The NIC will identify practical measures that its members and all organisations providing NHS services to patients can take to help overcome these barriers
  4. Support a culture shift within the NHS in favour of clinically- and cost-effective innovation

 

Small arrow Latest NIC work streams

Non-ST-Elevation Acute Coronary Syndromes

Improving NSTEACS patient outcomes and experience. The 2013 Cardiovascular Outcomes Strategy report highlighted that there is scope for improvement in the...

Nalmefene (NICETA 325)

Nalmefene (NICE TA 325) for reducing alcohol consumption in people with alcohol dependance. The NIC currently has a work stream looking at the implementation...
Small arrow Recent NIC work streams

Novel Oral Anti-coagulants (NOAC's)

  NICE Technology Appraisal guidance 249, 256 and the draft guidance for apixaban deal with the novel oral anticoagulants dabigatran etexilate and rivaroxaban and their use...

Denosumab (NICE TA204)

Denosumab (Prolia) is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fractures and is administered in the form of a 6-monthly...

Insulin Pumps (NICE TA 151)

Insulin Pumps are a proven way to reduce the long-term complications for patients with Type 1 Diabetes. They are small portable devices that provide precise dosing, giving...

BNP testing in heart failure (CG108)

Around 900,000 people in the UK have heart failure. Almost as many have damaged hearts but, as yet, no symptoms of heart failure. Both the incidence and prevalence of heart...
Small arrow Relevant NIC documents

NSTEACS clinical consensus documents published

The 2013 Cardiovascular Disease Outcomes Strategy drew attention to the need to improve access to timely treatment for patients with non-ST-elevation acute coronary syndromes (NSTEACS) and to...

Innovation Scorecard - Challenging Variation Report

Many of the medicines and medical technologies reviewed by the NIC are included in the quarterly Innovation Scorecard publication. The NHS England Innovation team produce a quarterly summary...

NICE Implementation Collaborative Concordat

Click here to download a copy of the NICE Implementation Collaborative Concordat which was signed by NIC partners in 2013.

Getting cost effective technologies into practice

This draft report produced for the NIC looks at a framework to assess the value to the NHS of investing in the implementation of NICE technologies. The report looks how the model could be applied...

Other relevant initiatives 

Horizontal line

Road map link

Innovation Compass link